VIVEVE MEDICAL INC. overview

Three-month study provides strategic path forward in SUI and will compare Viveve's cryogen-cooled monopolar radiofrequency (CMRF) treatment to cryogen-only treatment and to inert sham treatment ENGLEWOOD, CO / ACCESSWIRE / September 19, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it has submitted an Investigational Testing Application (ITA) to the Canadian Ministry of Health to conduct a three-arm, three-month...

ENGLEWOOD, CO / ACCESSWIRE / September 18, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that its Board of Directors has approved a one-for-100 reverse stock split of its common stock that is scheduled to become effective after trading closes on September 18, 2019. The company's common stock will begin trading on the Nasdaq Capital Market on a split adjusted basis when the market opens on September 19, 2019....

ENGLEWOOD, CO / ACCESSWIRE / September 17, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and director, will present at the Ladenburg Thalmann 2019 Healthcare Conference. Mr. Durbin will also meet with members of the investment community during one-on-one meetings at the conference. Event : Ladenburg Thalmann 2019 Healthcare Conference Date : Tuesday, September 24, 2019...

ENGLEWOOD, CO / ACCESSWIRE / September 3, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and director, will present at the H.C. Wainwright 21 st Annual Global Investment Conference. Mr. Durbin will also meet with members of the investment community during one-on-one meetings at the conference. Event : H.C. Wainwright 21 st Annual Global Investment Conference Date : Monday,...

Partnership strengthens Viveve commercialization efforts in major Asian markets ENGLEWOOD, CO / ACCESSWIRE / September 3, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced an exclusive partnership agreement with Paragon Meditech Co, Ltd., a leading women’s health and medical technology distributor throughout mainland China, Hong Kong and Macau. “We are excited to partner with Paragon Meditech as we continue to expand...

Company Expands North America Commercial Capabilities ENGLEWOOD, CO / ACCESSWIRE / August 22, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced an exclusive distribution agreement with Salient Medical Solutions, a leading distributor of innovative world-class medical devices and technologies in Canada. “We are pleased to partner with Salient Medical to expand the commercial availability of the Viveve® System to...

Company completed successful transition from capital sales to recurring revenue model Achieved U.S. FDA 510k and CE Mark clearances for Viveve 2.0 Expanded international distribution partnership in Middle East Company to host conference call at 4:30 pm ET today ENGLEWOOD, CO / ACCESSWIRE / August 8, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported financial results for the second quarter ended June 30, 2019. The company...

ENGLEWOOD, CO / ACCESSWIRE / August 7, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported additional clinical results from the LIBERATE-International Trial, a multicentered, randomized, double-blinded, sham-controlled trial to evaluate the safety and efficacy of Viveve’s proprietary, cryogen-cooled monopolar radiofrequency (CMRF) technology for the improvement of stress urinary incontinence (SUI) in women. Initial...